Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4361-4367

  Wang, Baosheng ^a   Sun, Shaolong ^a   Liu, Zhen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CXCR4 and CD4; Gene expression profiling; Immune system; Pancreatic cancer; Pathways

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; IMMUNE DYSREGULATION; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; PANCREAS CANCER; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PANCREAS TUMOR; PATHOLOGY;

ANTIGENS, CD4; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; IMMUNE SYSTEM; METABOLIC NETWORKS AND PATHWAYS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84903387370     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3307-2     Document Type: Article

References (28)

1. Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223(3):273
2. Kaiser MH, Ellenberg SS (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Ann Surg 120(8):899
3. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25(15):1960-1966 (Pubitemid 46972777)
4. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics. CA Cancer J Clin 55(1):10-30
5. Zhou J, Wellenius GA, Michaud DS (2012) Environmental tobacco smoke and the risk of pancreatic cancer among nonsmokers: a meta-analysis. Occup Environ Med 69(12):853-857
6. Muniraj T, Chari S (2012) Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol 58(4):331
7. Tramacere I, la Vecchia C (2011) Alcohol consumption and cancer risk. Nutr Cancer 63(7):983-990
8. Larsson SC, Bergkvist L, Wolk A (2006) Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84(5):1171-1176 (Pubitemid 44730389)
9. Farrow B, Evers BM (2002) Inflammation and the development of pancreatic cancer. Surg Oncol 10(4):153
10. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancerrelated inflammation. Nature 454(7203):436-444
11. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández- Porras I, Cañamero M, Rodriguez-Justo M, Serrano M, Barbacid M (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19(6):728-739
12. Grote V, Kaaks R, Nieters A, Tjønneland A, Halkjær J, Overvad K, Nielsen MRS, Boutron-Ruault M, Clavel-Chapelon F, Racine A (2012) Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer 106(11):1866-1874
13. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia: the authors reported a combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55(88):2016
14. Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1-13
15. Springer TA (1990) Adhesion receptors of the immune system. Nature 346(6283):425-434
16. Lasky LA (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258(5084):964-969
17. Martini R (1994) Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 23(1):1-28
18. Guttridge KL, Luft JC, Dawson TL, Kozlowska E, Mahajan NP, Varnum B, Earp HS (2002) Mer receptor tyrosine kinase signaling prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation. J Biol Chem 277(27):24057-24066 (Pubitemid 34951918)
19. Gao J-L, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185(11):1959-1968 (Pubitemid 27247082)
20. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D (1995) The functional role of the ELR motif in CXC chemokinemediated angiogenesis. J Biol Chem 270(45):27348-27357
21. Singh S, Singh UP, Grizzle WE, Lillard JW (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84(12):1666-1676 (Pubitemid 39600573)
22. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P (2004) Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64(22):8420-8427 (Pubitemid 39491782)
23. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Hori T (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6(9):3530-3535
24. Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K (2004) CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3(1):29-37 (Pubitemid 39193676)
25. Hill NJ, Van Gunst K, Sarvetnick N (2003) Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. J Immunol 170(4):1649-1658 (Pubitemid 36197378)
26. Van Der Meulen A, Biber K, Lukovac S, Balasubramaniyan V, Den Dunnen W, Boddeke H, Mooij J (2009) The role of CXC chemokine ligand (CXCL) 12-CXC chemokine receptor (CXCR) 4 signalling in the migration of neural stem cells towards a brain tumour. Neuropathol Appl Neurobiol 35(6):579-591
27. Zhao X, Yan X, Ju YF, Yu HM, Jiao SC (2012) Expression and clinical significance of CD3, CD4 and COX-2 in non-small cell lung cancer. Xi Bao Yu Fen ZiMian Yi Xue Za Zhi 28(4):407-409
28. Fukumura Y, Takase M, Mitani K, Suda K, Imamhasan A, Nobukawa B, Ueda A, Abe H, Yao T (2012) Amount of CD4+CD25+regulatory T cells in autoimmune pancreatitis and pilonidal sinus. Pancreas 41(6):910-915